ArtiFasciaTM First-in-Human clinical study has been successfully completed

  • ArtiFasciaTM First-in-Human clinical study has been successfully completed
  • 6 patients were implanted with ArtiFasciaTM with a 6 month follow-up period
  • No device related adverse events were reported during the entire study
  • No CSF leakage events occurred

Share This Post

Nurami Medical Nanofiber Technology © Copyright 2019

Designed & Created by Chen Ayala

we want to hear from you

Prof. Joachim Krauss

MD

Serves as Chairman of the of Department of

Neurosurgery at the Hannover Medical University Hospital, and Head of the

Commission for Technical Standards of the German Society of Neurosurgery, Secretary

of the European Society of Functional and Stereotactic Neurosurgery, and as Vice-

President of the World Society of Functional and Stereotactic Neurosurgery.

Agnesa Sharaev

Process Development Engineer and Production Manager

Agnesa Sharaev has 10 years’ of experience in process development engineering and

production management in the biotechnology field. Her expertise includes development of

bio-material scaffolds for tissue engineering, leading engineering processes such as

scaling-up and technology transfer. Agnesa is responsible for process development and

production management. Agnesa holds a B.Sc in Biotechnology Engineering from the Ort-

Braude college and certified as Quality Engineer from the Technion.

Skip to content